Meet with… Johnson & Johnson's GI leaders in Barcelona
Johnson & Johnson is seeking to connect with innovators developing innovative approaches that address the stromal and fibroinflammatory drivers of gastrointestinal (GI) disease.
If your work has the potential to transform outcomes for patients with fibrostenotic Crohn's disease, perianal fistulizing Crohn's disease, ulcerative colitis, eosinophilic esophagitis or related fibroinflammatory conditions, we invite you to apply for a 1:1 partnering meeting with our team.
Our areas of interest are listed below. Please note if you are not active in one of these areas, it is unlikely your request for a meeting will be accepted.
• Fibroinflammatory and stromal biology
• Precision cell depletion and stromal-targeted therapeutic strategies
• Tissue remodeling
• Oral and non-oral therapeutic modalities
• Biomarkers and patient stratification approaches
• Novel platforms and technologies targeting disease-driving fibroinflammatory pathways
Application deadline: 24 September, 17:00 CEST. Selected applicants will be notified by 1 October, 17:00 CEST
1:1 meetings are scheduled to take place in person at the UEWG congress (Fira Gran Via, Barcelona, Spain) on Monday 19 October, between 15:00 – 18:00 CEST.
To apply, please complete the form below.
